title: Striatal D2/acetylcholine interactions: PET studies of the vesamicol receptor.
abstract: The regional cerebral distribution of [18F]NEFA, an aminobenzovesamicol (ABV), was studied in primates with PET. The binding was stereoselective and could be blocked but not displaced with vesamicol. The regional distribution pattern at late times, striatum > cortex > cerebellum, was corroborated by in vitro autoradiography using [3H]ABV and is consistent with known patterns of cholinergic innervation. Pretreatment with sigma 1 or D1 antagonists did not affect the striatal uptake, whereas D2 antagonists markedly augmented the uptake. This is consistent with the known induction of acetylcholine turnover in the striatum in response to D2-receptor blockade and demonstrates that the amount of [18F]-(-)-NEFA incorporated was influenced by the cholinergic activity in the target neurones.
authors.affiliation: Karolinska Hospital, Stockholm, Karolinska, Sweden.
authors.forename: M
authors.initials: M
authors.lastname: Ingvar
authors.forename: S
authors.initials: S
authors.lastname: Stone-Elander
authors.forename: G A
authors.initials: GA
authors.lastname: Rogers
authors.forename: B
authors.initials: B
authors.lastname: Johansson
authors.forename: L
authors.initials: L
authors.lastname: Eriksson
authors.forename: S M
authors.initials: SM
authors.lastname: Parsons
authors.forename: L
authors.initials: L
authors.lastname: Widén
mesh_terms: D000109:Acetylcholine / Q000494:pharmacology*; D000818:Animals; D001345:Autoradiography; D001552:Benzazepines / Q000494:pharmacology; D001921:Brain / Q000000981:diagnostic imaging / Q000187:drug effects / Q000378:metabolism; D003342:Corpus Striatum / Q000033:anatomy & histology / Q000378:metabolism*; D065127:Dopamine D2 Receptor Antagonists; D005463:Fluoroacetates; D006220:Haloperidol / Q000494:pharmacology; D008252:Macaca fascicularis; D010880:Piperidines; D051381:Rats; D011950:Receptors, Cholinergic / Q000187:drug effects / Q000378:metabolism*; D017447:Receptors, Dopamine D1 / Q000037:antagonists & inhibitors; D017448:Receptors, Dopamine D2 / Q000187:drug effects / Q000378:metabolism*; D013237:Stereoisomerism; D014055:Tomography, Emission-Computed
chemical_list: D001552:Benzazepines; D065127:Dopamine D2 Receptor Antagonists; D005463:Fluoroacetates; D010880:Piperidines; D011950:Receptors, Cholinergic; D017447:Receptors, Dopamine D1; D017448:Receptors, Dopamine D2; C083232:vesamicol receptor; C084929:N-ethyl-4-fluoroacetamidobenzovesamicol; D006220:Haloperidol; D000109:Acetylcholine